Ki-67 expression in axillary lymph node metastases in breast cancer is prognostically significant

Human Pathology

Volumn 44, Issue 1, 2013, Pages 39-46

  Tawfik, Kareem ^a   Kimler, Bruce F ^a   Davis, Marilyn K ^a   Fan, Fang ^a   Tawfik, Ossama ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Immunohistochemistry; Invasive breast carcinoma; Ki 67; Lymph node metastasis; Survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEASUREMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR GROWTH; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; LYMPH NODES; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84870671819     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.05.007     Document Type: Article

References (25)

1. M.M. Black, T.H.C. Barclay, and B.F. Hankey Prognosis in breast cancer utilizing histologic characteristics of the primary tumor Cancer 36 1975 2048 2055
2. H.J.G. Bloom, and W.W. Richardson Histologic grading in breast cancer: a study of 1409 cases of which 359 have been followed for 15 years Br J Cancer 11 1957 359 377
3. P. Boiesen, P.O. Bendahl, and L. Anagnostaki Histologic grading in breast cancer-reproducibility between seven pathologic departments. South Sweden Breast Cancer Group Acta Oncol 39 2000 41 45
4. B. Cady, M.D. Stone, J.G. Schuler, R. Thakur, M.A. Wanner, and P.T. Lavin The new era in breast cancer. Invasion, size and nodal involvement dramatically decreasing as a result of mammography screening Arch Surg 131 1996 301 308
5. G. Cattoretti, M.H. Becker, and G. Key Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detects proliferating cells in microwave-processed formalin-fixed paraffin sections J Pathol 168 1992 357 363
6. P.L. Fitzgibbons, D.L. Page, and D. Weaver Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Medicine 124 2000 966 978
7. A.C. Wolff, M.E. Hammond, and J.N. Schwartz American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer J Clin Oncol 25 2007 118 145
8. W. Hilbe, A. Gachter, and H.C. Duba Comparison of automated cellular imaging system and manual microscopy for immunohistochemically stained cryostat sections of lung cancer specimens applying p53, Ki-67 and p120 Oncol Rep 10 2003 15 20
9. N. Bouzubar, K.J. Walker, and K. Griffiths Ki67 immunostaining in primary breast cancer: pathological and clinical associations Br J Cancer 59 1989 943 947
10. P. Jalava, T. Kuopio, L. Juntti-Patinen, T. Kotkansalo, P. Kronqvist, and Y. Collan Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index Histopathology 48 2006 674 682
11. R.L. Jansen, P.S. Hupperets, and J.W. Arends MIB-1 labelling index is an independent prognostic marker in primary breast cancer Br J Cancer 78 1998 460 465
12. A.P. Locker, K. Birrell, and J.A. Bell Ki67 immunoreactivity in breast carcinoma: relationships to prognostic variables and short term survival Eur J Surg Oncol 18 1992 224 229
13. S.E. Pinder, P. Wencyk, and D.M. Sibbering Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival Br J Cancer 71 1995 146 149
14. H. Trihia, S. Murray, and K. Price Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors - a surrogate marker? Cancer 97 2003 1321 1331
15. J. Gerdes, H. Lemke, H. Baisch, H.-H. Wacker, U. Schwab, and H. Stein Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 J Immunol 133 1984 1710 1715
16. H.A. Lehr, D.A. Hansen, and S. Kussick Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count Hum Pathol 30 1999 1314 1320
17. T. Petit, M. Wilt, and M. Velten Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients with neoadjuvant anthracycline based chemotherapy Eur J Cancer 40 2004 205 211
18. O. Tawfik, B.F. Kimler, and M. Davis Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count Virchows Arch 450 2007 627 636
19. C. Stasik, M. Davis, and B. Kimler Grading ductal carcinoma in situ of the breast using an automated proliferation index Annals Clin Lab Sci. 41 2011 122 130
20. C.W. Elston, and I.O. Ellis Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow up Histopathology 19 1991 403 410
21. R. Foster, and M. Costanza Breast self examination practices and breast cancer survival Cancer 53 1984 999 1105
22. E.N. Atkinson, B.W. Brown, and E.D. Montague Tumor volume, nodal status and metastasis in breast cancer in women J Natl Cancer Inst 76 1986 171 178
23. D. Park, R. Karesen, T. Noren, and T. Sauer Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications Virchows Arch 451 2007 11 18
24. F. Buxant, V. Anaf, P. Simon, I. Fayt, and J.C. Noel Ki-67 immunostaining activity is higher in positive axillary lymph nodes than in the primary breast tumor Breast Cancer Res Treat 75 2002 1 3
25. M. Gerlinger, A.J. Rowan, and S. Horswell Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N Engl J Med 366 2012 883 892